We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IFC:TSXIntact Financial Corporation Analysis

Data as of 2026-09-03 - not real-time

CA$266.31

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Intact Financial Corporation is neutral at CAD 266.31, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 7.9%. Relative strength is 40.4 — neutral — and the MACD signal is bullish. The recent range runs from support at CAD 261.53 up to resistance at CAD 281.87.
On valuation the read is undervalued — earnings multiple of 14.8 versus a 17.1 sector average, below the peer group. Consensus targets land 22.5% above where the shares trade now. Revenue is growing at 3.7% on a 12.4% profit margin. The 2.17% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 27.7%, a beta of -0.05 and a maximum drawdown of 15.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

Intact Financial TSX:IFC stands out as a steady financial to own, even as rates begin to rise again.Intact Financial stock has delivered a 78.Seeking Alpha1monIntact Financial Corporation IFC:CA Q2 2026 Earnings Call TranscriptAlso note that this call is being...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 270.41
  • MACD momentum is positive
  • 30-day price change of -7.9%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 14.8 versus sector average of 17.1
  • Trading below the 200-day average of 270.41
  • Analyst targets imply +22.5% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 14.8 versus sector average of 17.1
  • Analyst targets imply +22.5% versus the current price
  • Return on equity of 16.1%

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin12.39%
P/E Ratio14.8
ROE16.09%
ROA4.70%
Debt/Equity23.00
P/B Ratio2.3
Op. Cash FlowCA$4.2B
Free Cash FlowCA$5.3B
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI40.4
SupportCA$261.53
ResistanceCA$281.87
MA 20CA$268.93
MA 50CA$283.03
MA 200CA$270.41
MACDBullish
VolumeStable
Fear & Greed Index95.23

Valuation

Fair ValueCA$433.41
Target PriceCA$326.23
Upside/Downside22.50%
GradeUndervalued
TypeBlend
Dividend Yield2.17%

Risk Assessment

Beta-0.05
Volatility27.67%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.